Chemotherapy and Radiation
710 articles
Finding More Targets for Pancreatic Cancer Treatment
Dr. Noelle LoConte discusses a clinical trial for cancer patients, including pancreatic cancer patients, that have an NRG1 gene fusion.
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Studying One Family’s Mutations May Change Pancreatic Cancer Treatment and Prevention
Dr. Sahar Nissim is studying the genetic mutations in one family predisposed to pancreatic cancer, to find new ways to combat the disease.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
No Time to Wait: UK Pancreatic Cancer Patients Struggle with Treatment and Diagnostic Delays
Peter De Rosa of Pancreatic Cancer UK provides an update on how the COVID-19 pandemic has impacted pancreatic cancer patients in the UK.
For Families at Risk, Remote Education May Be Key in Improving Genetic Testing Uptake
What’s the best way to educate families at risk for pancreatic cancer about genetic testing? Dr. Sapna Syngal discusses the results of the GENERATE study.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
A Clinical Trial Matches My Genetics
Steven Merlin learned that he carried the BRCA2 mutation after he developed pancreatic cancer. He researched and found a clinical trial for BRCA carriers.
Higher Glucose Levels May Improve Chemotherapy Effectiveness
Can higher glucose levels make chemotherapy more effective? Dr. Jordan Winter and colleagues are studying the relationship.
Before You Leap: Genetic Testing for Pancreatic Cancer
Genetic counselor Megan Frone outlines the advantages of genetic testing when there is a family history of pancreatic cancer.
New Clinical Accelerator Initiative Shortens Time from Bench to Clinic
Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.
The Association of Community Cancer Centers (ACCC) Fights for Equitable Cancer Care
The Association of Community Cancer Centers helps local oncologists access the latest treatment and care information, says Dr. Leigh Boehmer.
USAF Veteran PJ, Author, Entrepreneur, and Survivor of CHF and Pancreatic Cancer
Dr. James Moss has followed many different pursuits in his life but now he can call himself a pancreatic cancer survivor.
Scanxiety—A Nearly Universal Experience Among Cancer Patients
Social worker Lauren Shaffer provides tips and insights into managing scanxiety, the worry that accompanies follow-up scans and tests for cancer patients.
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.